atomoxetine hydrochloride has been researched along with Anxiety Disorders in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, YS; Khoodoruth, MAS; Ouanes, S | 1 |
| Chaplin, MM; León-Barriera, R; Modesto-Lowe, V; Ortegon, RS | 1 |
| Clarke, S; Efron, D; Griffiths, KR; Hermens, DF; Kohn, MR; Leikauf, JE; Tsang, TW; Williams, LM | 1 |
| Antoniazzi, S; Carnovale, C; Clementi, E; Gentili, M; Nobile, M; Peeters, GGAM; Pozzi, M; Radice, S | 1 |
| Chierrito, D; Fernandez-Llimos, F; Sanches, ACC; Tonin, FS; Villas-Boas, CB | 1 |
| Guney, E; Uneri, OS | 1 |
| Anderson, RH; Mattingly, GW | 1 |
| Allen, AJ; D'souza, DN; Emslie, GJ; Kratochvil, C; Newcorn, JH; Schuh, LM; Sutton, VK; Wilens, T; Zhang, S | 1 |
| Spencer, TJ; Wilens, TE | 1 |
| Gabriel, A; Violato, C | 1 |
| Adler, L; Hedges, DW; Marchant, BK; Reimherr, FW; Soni, P; Spencer, TJ; Strong, RE; West, SA | 1 |
| Dewan, M; Faraone, SV; Kunwar, A | 1 |
| Bakken, R; Donnelly, C; Geller, D; Kelsey, D; Lopez, F; Newcorn, J; Paczkowski, M; Rubin, R; Sumner, C; Sutton, V | 1 |
| Bangerl, W; Friedrich, M; Kienbacher, C; Pellegrini, E; Scheidinger, H; Vesely, C; Wiesegger, G | 1 |
| Harris, DK; Párraga, HC; Párraga, MI | 1 |
9 review(s) available for atomoxetine hydrochloride and Anxiety Disorders
| Article | Year |
|---|---|
A systematic review of the use of atomoxetine for management of comorbid anxiety disorders in children and adolescents with attention-deficit hyperactivity disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Anxiety; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Humans; Propylamines; Treatment Outcome | 2022 |
Treating ADHD and Comorbid Anxiety in Children: A Guide for Clinical Practice.
Topics: Adolescent; Anxiety; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Humans | 2023 |
Adverse drug events related to mood and emotion in paediatric patients treated for ADHD: A meta-analysis.
Topics: Affect; Affective Symptoms; Anxiety; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Mood Disorders; Personality Disorders | 2018 |
Pharmacological treatment of attention-deficit hyperactivity disorder comorbid with an anxiety disorder: a systematic review.
Topics: Adolescent; Adult; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Agents; Child; Comorbidity; Desipramine; Double-Blind Method; Female; Fluvoxamine; Humans; Male; Methylphenidate; Randomized Controlled Trials as Topic; Treatment Outcome | 2019 |
Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Clonidine; Comorbidity; Delayed-Action Preparations; Depressive Disorder; Dextroamphetamine; Guanfacine; Humans; Methylphenidate | 2016 |
Characteristics of placebo responders in pediatric clinical trials of attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Multicenter Studies as Topic; Personality Assessment; Placebo Effect; Propylamines; Randomized Controlled Trials as Topic; Research Design | 2009 |
Understanding attention-deficit/hyperactivity disorder from childhood to adulthood.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Humans; Magnetic Resonance Imaging; Mood Disorders; Propylamines; Psychotherapy; Remedial Teaching; Substance-Related Disorders | 2010 |
Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Comorbidity; Depressive Disorder, Major; Humans; Mental Disorders; Prevalence; Propylamines | 2007 |
[Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].
Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Comorbidity; Contraindications; Cross-Sectional Studies; Drug Therapy, Combination; Humans; Mood Disorders; Nortriptyline; Practice Guidelines as Topic; Propylamines; Randomized Controlled Trials as Topic; Tic Disorders | 2007 |
4 trial(s) available for atomoxetine hydrochloride and Anxiety Disorders
| Article | Year |
|---|---|
Response inhibition and emotional cognition improved by atomoxetine in children and adolescents with ADHD: The ACTION randomized controlled trial.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cognition Disorders; Cohort Studies; Cross-Over Studies; Double-Blind Method; Female; Humans; Inhibition, Psychological; Male; Psychiatric Status Rating Scales; Treatment Outcome | 2018 |
Adjunctive atomoxetine to SSRIs or SNRIs in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety (GA): an open-label study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Body Weight; Drug Resistance; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Middle Aged; Propylamines; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors | 2011 |
Emotional dysregulation in adult ADHD and response to atomoxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Affective Symptoms; Analysis of Variance; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Norepinephrine; Propylamines | 2005 |
Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder.
Topics: Adrenergic Uptake Inhibitors; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Propylamines | 2007 |
2 other study(ies) available for atomoxetine hydrochloride and Anxiety Disorders
| Article | Year |
|---|---|
Atomoxetine-induced hypomania-like symptoms in a preadolescent patient.
Topics: Adrenergic Uptake Inhibitors; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Humans; Male; Propylamines | 2014 |
Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder.
Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Citalopram; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Propylamines; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Tics | 2007 |